| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.06. | Pluri Inc.: U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract | 1 | GlobeNewswire (USA) | ||
| 31.05. | Pluri Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.05. | Pluri Inc.: Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale | 1 | GlobeNewswire (USA) | ||
| 09.05. | Pluri Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 09.05. | Pluri Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 02.05. | Pluri Inc.: Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment | 148 | GlobeNewswire (Europe) | Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical needMAIT... ► Artikel lesen | |
| 17.04. | Pluri Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | Pluri Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.03. | Pluri Inc.: Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences | 4 | GlobeNewswire (USA) | ||
| 27.03. | Pluri Inc. Announces 1-for-8 Reverse Share Split | 141 | GlobeNewswire (Europe) | HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the "Company"), a leading biotechnology company that transforms cells into solutions, today announced... ► Artikel lesen | |
| 21.03. | Pluri Inc.: Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report | 2 | GlobeNewswire (USA) | ||
| 19.03. | Pluri Inc.: Engage with Pluri's Talent: Exciting Conference Appearances Ahead | 2 | GlobeNewswire (USA) | ||
| 14.03. | Pluri Inc.: Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing | 333 | GlobeNewswire (Europe) | HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today announced... ► Artikel lesen | |
| 11.03. | Pluri Inc. secures patent for agtech cell expansion | 1 | Investing.com | ||
| 06.03. | Pluri Inc. adds James Roosevelt Jr. to advisory board | 1 | Investing.com | ||
| 06.03. | Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board | 1 | GlobeNewswire (USA) | ||
| 13.02. | Pluri Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 12.02. | Pluri Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 24.01. | Pluri Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 23.01. | Pluri Inc.: Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis | 5 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 3.937 |
| NVIDIA | 2.772 |
| TUI | 2.184 |
| GAMESTOP | 1.937 |
| BAYER | 1.635 |
| NEL | 1.562 |
| RHEINMETALL | 1.375 |
| BYD | 1.180 |
| DEUTSCHE LUFTHANSA | 1.065 |
| TESLA | 791 |
| VOLKSWAGEN | 769 |
| CARL ZEISS MEDITEC | 634 |
| BASF | 603 |
| APPLE | 586 |
| SNOWFLAKE | 586 |
| COMMERZBANK | 575 |
| THYSSENKRUPP | 570 |
| AIXTRON SE | 566 |
| PORSCHE SE | 560 |
| DEFI TECHNOLOGIES | 557 |
| SUPER MICRO COMPUTER | 547 |
| CAVENDISH HYDROGEN | 497 |
| DEUTSCHE BANK | 483 |
| MERCEDES-BENZ | 478 |
| ALLIANZ | 465 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
